NCT00011167View on ClinicalTrials.gov

Retinal Arteriolar Abnormalities and CV Mortality

CompletedOBSERVATIONAL
Enrollment

1,380

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Cardiovascular DiseasesHeart DiseasesCerebrovascular DisordersCoronary Disease
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00011167 - Retinal Arteriolar Abnormalities and CV Mortality | Biotech Hunter | Biotech Hunter